Together, these data demonstrate that PARP‐1 enzymatic activity is heterogeneous, increases as a function of PCa progression, is not associated with levels of either PARP‐1 protein expression or of DNA damage repair in mCRPC, and may predict poor outcome in PCa. Here, PARP1 is linked to posterior cortical atrophy.